Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

Jai Perumal^*, Roumen Balabanov, Ray Su, Roger Chang, Laura Balcer, Steven Galetta, Denise I. Campagnolo, Robin Avila, Lily Lee, Danette Rutledge, Robert J. Fox

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

1 results
- Title
- Start date(ascending)

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Perumal, J. (Creator), Balabanov, R. (Creator), Su, R. (Creator), Chang, R. (Creator), Balcer, L. (Creator), Galetta, S. (Creator), Campagnolo, D. I. (Creator), Avila, R. (Creator), Lee, L. (Creator), Rutledge, D. (Creator) & Fox, R. J. (Creator), Adis Journals, 2021
DOI: 10.6084/m9.figshare.14248406.v1, https://adisjournals.figshare.com/articles/media/Natalizumab_in_Early_Relapsing-Remitting_Multiple_Sclerosis_A_4-Year_Open-Label_Study/14248406/1
Dataset